Del Rosario, Jaime L.

HRN: 08-51-34  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/26/2023
12/24/2023
IV
1.5gram
Q8hrs
Infected Wound, DM Foot
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: